Abbott Labs profit tops forecasts on greater Humira sales, raises 2009 profit viewNORTH CHICAGO, Ill. — Abbott Laboratories said Wednesday it beat its own expectations for the third quarter as sales of its drug Humira continued to climb, along with sales of medical products and nutritional formula for children. Abbott Laboratories’ 2nd-quarter profit falls on charges but lead drug regains sales momentumDrug developer and medical device maker Abbott Laboratories said Wednesday its second-quarter profit fell 3 percent on a mix of buyout charges and lower drug sales, but the results still met Wall Street forecasts. |